Currently predicting for Mon, 1 Apr 2024

Trading levels for CRBP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 42.92 9.37 %
R2 41.09 4.70 %
R1 39.95 1.82 %
Current price: 39.24
Support S1 36.29 -7.52 %
S2 35.16 -10.41 %
S3 33.32 -15.07 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 44.93 14.50 %
R2 43.68 11.31 %
R1 40.32 2.75 %
Current price 39.24
Support S1 34.60 -11.82%
S2 30.90 -21.25%
S3 29.49 -24.85%

CRBP Predictions History

4 years ago
PumpTheseNumbers predicted that CRBP for 2019-04-10 is going $7.28 (3.85%)

5 years ago
PumpTheseNumbers predicted that CRBP for 2019-03-21 is going $7.47 (-2.73%)

5 years ago
Gp predicted that CRBP for 2019-03-18 is going $7.11 (3.49%)

5 years ago
Greg.Struble.104429 predicted that CRBP for 2019-03-18 is going $8.41 (25.52%)

Rank:

5 years ago
seyedsepehr.kimiai.14173 predicted that CRBP for 2019-03-18 is going $7.61 (13.58%)

Rank:

5 years ago
JS predicted that CRBP for 2019-03-18 is going $6.58 (-1.79%)

5 years ago
PumpTheseNumbers predicted that CRBP for 2019-03-18 is going $6.94 (3.58%)

5 years ago
JS predicted that CRBP for 2019-03-05 is going $6.06 (5.21%)

5 years ago
Gp predicted that CRBP for 2019-03-04 is going $5.26 (-16.51%)

5 years ago
PumpTheseNumbers predicted that CRBP for 2019-03-04 is going $6.94 (10.16%)

Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT